Efficacy and Safety of Tranexamic Acid in Reducing Hidden Blood Loss During Kyphoplasty .
Efficacy and Safety of Tranexamic Acid on Hidden Blood Loss in Osteoporotic Vertebral Compression Fractures Patients Treated with Percutaneous Kyphoplasty: A Prospective Randomized Controlled Trial.
Ther Clin Risk Manag . 2024 Dec 25:20:907-917.One hundred forty-six patients with osteoporotic vertebral compression fractures undergoing percutaneous kyphoplasty were randomized to receive intravenous tranexamic acid (1g, n=75) or placebo (n=71). The primary outcome was hidden blood loss (HBL) on postoperative days 1 and 3. Secondary outcomes included hemoglobin and hematocrit changes, VAS pain scores, and postoperative complications. Outcomes were assessed up to one month postoperatively. Overall, the results of the study revealed that TXA significantly reduced HBL on both POD1 and POD3, and improved early postoperative pain scores without increasing the rate of complications. These findings suggest that intravenous TXA is effective and safe for reducing HBL and early postoperative pain in this patient population.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
